NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING

NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING

Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF) showed that new direct oral anticoagulants (DOACs) were just as effective at preventing stroke and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk of...

Full description

Bibliographic Details
Main Authors: Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2018-05-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
atrial fibrillation
anticoagulants
real-world data
apixaban
Online Access:https://www.rpcardio.com/jour/article/view/1662

Similar Items

Similar Items